General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The total neurovascular stent market includes both traditional neurovascular stents and flow diversion stents. There will a slight decrease in market value of the neurovascular stent market due to price decreases from competitive pressure in the stent market and in other new medical devices for the treatment of aneurysms.
Traditional stents are experiencing a slight decline in units sold due to the cannibalization of the market by flow diverter stents. The use of the latter is becoming more popular than stent assisted coiling which is limiting the growth in the traditional stent market. Approximately 1.1 stents are used per stenting procedure, as a small percentage of patients require multiple stents.
Flow diverter stents will continue to experience low growth; however, they will also face competition from new products posed to enter the market. These increases in unit sales will also be driven by innovation in these devices making them smaller and able to place in more distal locations.
The price of the flow diverter stents is significantly higher than the price of traditional stents and will remain high over the forecast period. Both types of stents will experience a reduction in their ASP due to competitive pressure. There are heavy price pressures seen with the stents, as smaller new entrants enter the market with significantly lower prices. The flow diverter stent will decrease at a slightly quicker rate since it is currently at such a high price premium and will need to stay competitive with innovative new products. Over the forecast period, the flow diverter stents will make up a larger portion of the market than the traditional stents. This trend will continue unless more evidence arises to demonstrate the safety and efficacy of traditional stents.
'
TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XII
EXECUTIVE SUMMARY 1
EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
MARKETS INCLUDED 11
PROCEDURES INCLUDED 12
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.2 DISEASE PATHOLOGY AND DISORDERS 28
2.2.1 Introduction 28
2.2.2 General Diagnostics and Neurosurgery 30
2.2.3 Tumor and Brain Cancer 32
2.2.4 Brain Arteriovenous Malformations 34
2.2.5 Ischemic Stroke 35
2.2.6 Brain Aneurysm 36
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure 38
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder 38
2.2.7.2 Cerebral Edema 39
2.2.8 Indication for Neuromodulation 41
2.2.9 Traumatic brain injury 43
COUNTRY PROFILES 44
3.1 INTRODUCTION 44
3.1.1 Population 44
3.1.2 GDP Per Capita 44
3.1.3 Price Index 44
3.2 GERMANY 45
3.3 FRANCE 46
3.4 UNITED KINGDOM 47
3.5 ITALY 48
3.6 SPAIN 49
3.7 BENELUX 50
3.8 SCANDINAVIA 51
3.9 AUSTRIA 52
3.10 SWITZERLAND 53
3.11 PORTUGAL 54
PRODUCT ASSESSMENT 55
4.1 PRODUCT PORTFOLIOS 55
4.1.1 Neurovascular Stent 55
4.1.1.1 Introduction 55
4.1.1.2 Product Matrix for Neurovascular Stent Market: Core Companies 58
4.2 REGULATORY ISSUES AND RECALLS 59
4.2.1 Neurovascular Stent 59
4.3 CLINICAL TRIALS 60
4.3.1 Neurovascular Stent 60
NEUROVASCULAR STENT MARKET 64
5.1 INTRODUCTION 64
5.2 MARKET OVERVIEW 66
5.3 MARKET ANALYSIS AND FORECAST 70
5.3.1 Total Neurovascular Stent Market 70
5.3.2 Traditional Neurovascular Stent Market 77
5.3.3 Flow Diversion Stent Market 84
5.4 DRIVERS AND LIMITERS 91
5.4.1 Market Drivers 91
5.4.2 Market Limiters 92
5.5 COMPETITIVE MARKET SHARE ANALYSIS 95
ABBREVIATIONS 100
APPENDIX: COMPANY PRESS RELEASES 103
Chart 1 1: Neurological Device Market by Segment, Europe, 2013 – 2023 2
Chart 1 2: Neurological Device Market Overview, Europe, 2013 &2023 2
Chart 3 1: Country Profile, Germany, 2016 45
Chart 3 2: Country Profile, France, 2016 46
Chart 3 3: Country Profile, United Kingdom, 2016 47
Chart 3 4: Country Profile, Italy, 2016 48
Chart 3 5: Country Profile, Spain, 2016 49
Chart 3 6: Country Profile, Benelux, 2016 50
Chart 3 7: Country Profile, Scandinavia, 2016 51
Chart 3 8: Country Profile, Austria, 2016 52
Chart 3 9: Country Profile, Switzerland, 2016 53
Chart 3 10: Country Profile, Portugal, 2016 54
Chart 5 1: Neurovascular Stent Market by Segment, Europe, 2013 – 2023 68
Chart 5 2: Neurovascular Stent Market Breakdown, Europe, 2016 69
Chart 5 3: Neurovascular Stent Market Breakdown, Europe, 2023 69
Chart 5 4: Total Neurovascular Stent Market, Europe, 2013 – 2023 71
Chart 5 5: Traditional Neurovascular Stent Market, Europe, 2013 – 2023 78
Chart 5 6: Flow Diversion Stent Market, Europe, 2013 – 2023 85
Chart 5 7: Leading Competitors, Neurovascular Stent Market, Europe, 2016 99
Figure 1 1: Neurological Device Market Share Ranking by Segment, Europe, 2016 (1 of 3) 4
Figure 1 2: Neurological Device Market Share Ranking by Segment, Europe, 2016 (2 of 3) 4
Figure 1 3: Neurological Device Market Share Ranking by Segment, Europe, 2016 (3 of 3) 5
Figure 1 4: Companies Researched in this Report, Europe, 2016 6
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, Europe (1 of 3) 7
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, Europe (2 of 3) 8
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, Europe (3 of 3) 9
Figure 1 8: Recent Events in the Neurological Device Market, Europe, 2014 – 2016 10
Figure 1 9: Neurological Device Markets Covered, Europe, 2016 11
Figure 1 10: Neurological Device Procedures Covered, Europe, 2016 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Neurology Disease Overview 29
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016 33
Figure 4 1: Class 2 Device Recall: Pipeline and Pipeline Flex 59
Figure 4 2: Class 2 Device Recall: Stryker brand Neuroform 3 Microdelivery Stent System 59
Figure 4 3: Class 2 Device Recall: Wingspan Stent System 59
Figure 4 4: Neurovascular Stent: Safety and Effectiveness of an Intracranial Aneurysm Embolization System 60
Figure 4 5: Neurovascular Stent: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device (VRD) 60
Figure 4 6: Neurovascular Stent: Flow Diverter Stent for Endovascular Treatment of Unruptured Saccular Wide-necked Intracranial Aneurysms (EVIDENCE) 61
Figure 4 7: Neurovascular Stent: Complete Occlusion of Coilable Aneurysms (COCOA) 61
Figure 4 8: Neurovasculr Stents: VISSIT Intracranial Stent Study for Ischemic Therapy (VISSIT) 62
Figure 4 9: Neurovasculr Stents: The Registry to Study Safety and Performance of the CORDIS Vascular Reconstruction Device and Delivery System (SUNRISE) 62
Figure 4 10: Neurovasculr Stents: Enterprise Stent Aneurysm Treatment (ESAT) Study - France (ESAT) 63
Figure 5 1: Neurovascular Stent Market, Europe, 2013 – 2023 (€M) 67
Figure 5 2: Neurovascular Stent Market, Europe, 2013 – 2023 (US$M) 67
Figure 5 3: Total Neurovascular Stent Market, Europe, 2013 – 2023 (€ and US$) 70
Figure 5 4: Units Sold by Country, Total Neurovascular Stent Market, Europe, 2013 – 2023 72
Figure 5 5: Average Selling Price by Country, Total Neurovascular Stent Market, Europe, 2013 – 2023 (€) 73
Figure 5 6: Average Selling Price by Country, Total Neurovascular Stent Market, Europe, 2013 – 2023 (US$) 74
Figure 5 7: Market Value by Country, Total Neurovascular Stent Market, Europe, 2013 – 2023 (€M) 75
Figure 5 8: Market Value by Country, Total Neurovascular Stent Market, Europe, 2013 – 2023 (US$M) 76
Figure 5 9: Traditional Neurovascular Stent Market, Europe, 2013 – 2023 (€ and US$) 77
Figure 5 10: Units Sold by Country, Traditional Neurovascular Stent Market, Europe, 2013 – 2023 79
Figure 5 11: Average Selling Price by Country, Traditional Neurovascular Stent Market, Europe, 2013 – 2023 (€) 80
Figure 5 12: Average Selling Price by Country, Traditional Neurovascular Stent Market, Europe, 2013 – 2023 (US$) 81
Figure 5 13: Market Value by Country, Traditional Neurovascular Stent Market, Europe, 2013 – 2023 (€M) 82
Figure 5 14: Market Value by Country, Traditional Neurovascular Stent Market, Europe, 2013 – 2023 (US$M) 83
Figure 5 15: Flow Diversion Stent Market, Europe, 2013 – 2023 (€ and US$) 84
Figure 5 16: Units Sold by Country, Flow Diversion Stent Market, Europe, 2013 – 2023 86
Figure 5 17: Average Selling Price by Country, Flow Diversion Stent Market, Europe, 2013 – 2023 (€) 87
Figure 5 18: Average Selling Price by Country, Flow Diversion Stent Market, Europe, 2013 – 2023 (US$) 88
Figure 5 19: Market Value by Country, Flow Diversion Stent Market, Europe, 2013 – 2023 (€M) 89
Figure 5 20: Market Value by Country, Flow Diversion Stent Market, Europe, 2013 – 2023 (US$M) 90
Figure 5 21: Drivers and Limiters, Neurovascular Stent Market, Europe, 2016 94
Figure 5 22: Leading Competitors, Neurovascular Stent Market, Europe, 2016 98
Figure 7 1: Press Release Summary 103
Medtronic
Stryker
Codman & Shurtleff, Inc.
St. Jude Medical
Nevro
Carl Zeiss
Boston Scientific
LivaNova
Terumo MicroVention
Penumbra Inc.
Leica
Integra LifeSciences
BrainLab
Balt
Magstim
Phenox
MagVenture
Elekta
Moëller Wedel
Misonix
Sophysa
Aesculap
MAG & More
Neurosoft
Acandis
Soring
Brainsway
Nexstim
Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
